Updated Blue Spoon Consulting briefing note available for web download

NewsGuard 100/100 Score

Blue Spoon Consulting Group, LLC, today updated its briefing note examining the degrading trends in pharmaceutical marketing, and what can be done about it. Available for download through the Blue Spoon Consulting website (www.bluespoonconsulting.com), ‘Pharmaceutical Promotion At Its Productivity Frontier’ is currently the only piece of strategic writing that looks at a total context of change shaping how pharmaceutical companies market and measure performance. It is updated periodically to integrate significant industry events. Opportunity to create new platforms for growth is also explored.

Blue Spoon is a leading strategy and marketing innovation consultancy serving the global pharmaceutical, health products, and information technology industries. Blue Spoon was the first to publish a new commercial model for drug marketing1, the first to design a new architecture for grand strategy in the pharmaceutical industry, and has pioneered a framework to improve business performance at a system level, an approach that enables an evolutionary leap in solutions for growth and competitive advantage.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative levodopa infusion pump trial shows promise for reducing Parkinson's symptoms